Home > Entertainment > Watch your stocks: Dow, S&P 500 ends trade on record levels amid improved US outlook
opoyicentral
Opoyi Central

3 years ago .New York, NY, USA

Watch your stocks: Dow, S&P 500 ends trade on record levels amid improved US outlook

  • The benchmark Dow Jones Industrial Average climbed 0.5% to end the day at 32,953.46
  • The broad-based S&P 500 gained 0.7% to finish at 3,968.94
  • The tech-rich Nasdaq Composite Index gained 1.1% to finish at 13,459.71

Written by:Shivam
Published: March 15, 2021 08:47:38 New York, NY, USA

The Dow and S&P 500 again closed at records on Monday, as Wall Street traders continued to bet COVID-19 vaccines and government stimulus would heal the US economy.

The benchmark Dow Jones Industrial Average climbed 0.5% to end the day at 32,953.46, while the broad-based S&P 500 gained 0.7% to finish at 3,968.94 — the second day in a row the two indices closed at all-time highs.

The tech-rich Nasdaq Composite Index, which has seen significant volatility in recent weeks as inflation fears kept traders away from riskier tech stocks, gained 1.1% to finish at 13,459.71.

“You still have that rotation from new economy stocks into the old economy stocks,” said Peter Cardillo of Spartan Capital Securities.

However, the sell-off in tech appears to have found its limits, he said, pointing to Apple’s 2.5% rise and Cisco’s 1.2% gain, even as Amazon and Microsoft closed lower.

“It looks as it’s bottomed out, but I don’t think the rotation is totally over with,” he said.

But lingering inflation fears that manifested themselves in rising bond yields took some of the momentum out of Wall Street indices, which have been boosted over the past year by the Federal Reserve’s ultra-easy lending policies and massive government stimulus spending.

Markets are awaiting the results of a $1.9 trillion stimulus package President Joe Biden signed last week, as well as the two-day Fed meeting beginning Tuesday in which central bankers will almost certainly keep interest rates at zero but may address the inflation concerns.

Gilead finished 2.5% higher and Merck rose  2.2% after the two companies announced they were collaborating on a drug to treat HIV that could be taken less often than the daily medications currently in use.

#US

Related Articles

ADVERTISEMENT

© Copyright 2023 Opoyi Private Limited. All rights reserved